Literature DB >> 21340522

Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.

Arne Fischmann1, Monika Gloor, Susanne Fasler, Tanja Haas, Rachele Rodoni Wetzel, Oliver Bieri, Stephan Wetzel, Karl Heinimann, Klaus Scheffler, Dirk Fischer.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD) is a progressive skeletal muscle dystrophy characterized by ptosis, dysphagia, and upper and lower extremity weakness. We examined eight genetically confirmed OPMD patients to detect a MRI pattern and correlate muscle involvement, with validated clinical evaluation methods. Physical assessment was performed using the Motor Function Measurement (MFM) scale. We imaged the lower extremities on a 1.5 T scanner. Fatty replacement was graded on a 4-point visual scale. We found prominent affection of the adductor and hamstring muscles in the thigh, and soleus and gastrocnemius muscles in the lower leg. The MFM assessment showed relative mild clinical impairment, mostly affecting standing and transfers, while distal motor capacity was hardly affected. We observed a high (negative) correlation between the validated clinical scores and our visual imaging scores suggesting that quantitative and more objective muscle MRI might serve as outcome measure for clinical trials in muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340522     DOI: 10.1007/s00415-011-5937-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Variability of the recessive oculopharyngeal muscular dystrophy phenotype.

Authors:  Alexander Semmler; Wolfram Kress; Stefan Vielhaber; Rolf Schröder; Cornelia Kornblum
Journal:  Muscle Nerve       Date:  2007-05       Impact factor: 3.217

2.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.

Authors:  B Brais; J P Bouchard; Y G Xie; D L Rochefort; N Chrétien; F M Tomé; R G Lafrenière; J M Rommens; E Uyama; O Nohira; S Blumen; A D Korczyn; P Heutink; J Mathieu; A Duranceau; F Codère; M Fardeau; G A Rouleau; A D Korcyn
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Oculopharyngeal muscular dystrophy in France.

Authors:  M Fardeau; F M Tomé
Journal:  Neuromuscul Disord       Date:  1997-10       Impact factor: 4.296

Review 4.  Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.

Authors:  Xueping Fan; Guy A Rouleau
Journal:  Can J Neurol Sci       Date:  2003-02       Impact factor: 2.104

5.  Magnetic resonance imaging and computed tomography of skeletal muscles in oculopharyngeal muscular dystrophy.

Authors:  Molly K King; Roland R Lee; Larry E Davis
Journal:  J Clin Neuromuscul Dis       Date:  2005-03

6.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

7.  Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan.

Authors:  D Goutallier; J M Postel; J Bernageau; L Lavau; M C Voisin
Journal:  Clin Orthop Relat Res       Date:  1994-07       Impact factor: 4.176

8.  Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita.

Authors:  C Kornblum; G G Lutterbey; B Czermin; J Reimann; J-C von Kleist-Retzow; K Jurkat-Rott; M P Wattjes
Journal:  Acta Neurol Scand       Date:  2009-12-28       Impact factor: 3.209

9.  Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.

Authors:  K Kesper; C Kornblum; J Reimann; G Lutterbey; R Schröder; M P Wattjes
Journal:  Acta Neurol Scand       Date:  2008-12-22       Impact factor: 3.209

Review 10.  Neuromuscular imaging in inherited muscle diseases.

Authors:  Mike P Wattjes; Rudolf A Kley; Dirk Fischer
Journal:  Eur Radiol       Date:  2010-04-27       Impact factor: 5.315

View more
  13 in total

Review 1.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

2.  MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.

Authors:  Leo H Wang; Seth D Friedman; Dennis Shaw; Lauren Snider; Chao-Jen Wong; Chris B Budech; Sandra L Poliachik; Nancy E Gove; Leann M Lewis; Amy E Campbell; Richard J F L Lemmers; Silvère M Maarel; Stephen J Tapscott; Rabi N Tawil
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

3.  Quantitative MRI can detect subclinical disease progression in muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Susanne Fasler; Monika Gloor; Oliver Bieri; Ueli Studler; Dirk Fischer
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

4.  Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Authors:  Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Ann Neurol       Date:  2016-02-19       Impact factor: 10.422

5.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Monika Gloor; Maurice Schmid; Andrea Klein; Urs Pohlman; Tanja Waltz; Rocio Gonzalez; Tanja Haas; Oliver Bieri; Dirk Fischer
Journal:  J Neurol       Date:  2012-11-09       Impact factor: 4.849

6.  Clinical and muscle imaging findings in 14 mainland chinese patients with oculopharyngodistal myopathy.

Authors:  Juan Zhao; Jing Liu; Jiangxi Xiao; Jing Du; Chengli Que; Xin Shi; Wei Liang; Weiping Sun; Wei Zhang; He Lv; Yun Yuan; Zhaoxia Wang
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.

Authors:  Patricia Hafner; Ulrike Bonati; Daniela Rubino; Vanya Gocheva; Thomas Zumbrunn; Nuri Gueven; Dirk Fischer
Journal:  Trials       Date:  2016-08-03       Impact factor: 2.279

8.  Longitudinal characterization of biomarkers for spinal muscular atrophy.

Authors:  Ulrike Bonati; Štefan Holiga; Nicole Hellbach; Céline Risterucci; Tobias Bergauer; Wakana Tang; Patricia Hafner; Alain Thoeni; Oliver Bieri; Irene Gerlach; Anne Marquet; Omar Khwaja; Fabio Sambataro; Alessandro Bertolino; Juergen Dukart; Arne Fischmann; Dirk Fischer; Christian Czech
Journal:  Ann Clin Transl Neurol       Date:  2017-04-11       Impact factor: 4.511

9.  Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial.

Authors:  Simone Schmidt; Vanya Gocheva; Thomas Zumbrunn; Daniela Rubino-Nacht; Ulrike Bonati; Dirk Fischer; Patricia Hafner
Journal:  Trials       Date:  2017-03-09       Impact factor: 2.279

10.  Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.

Authors:  Charlotte Gineste; Guillaume Duhamel; Yann Le Fur; Christophe Vilmen; Patrick J Cozzone; Kristen J Nowak; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.